EGFR-TKIs疗效预测相关论文
厄洛替尼是一种表皮生长因子受体(epidermal growth factor receptor,EGFR)酪氨酸激酶抑制剂(tyrosine kinase inhibitor,TKI),其......
厄洛替尼是一种表皮生长因子受体（epidermal growth factor receptor,EGFR）酪氨酸激酶抑制剂（tyrosine kinase inhibitor,TKI）,其联合......
